PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Peifer, M.* ; Fernández-Cuesta, L.* ; Sos, M.L.* ; George, J.* ; Seidel, D.* ; Kasper, L.H.* ; Plenker, D.* ; Leenders, F.* ; Sun, R.* ; Zander, T.* ; Menon, R.* ; Koker, M.* ; Dahmen, I.* ; Müller, C.* ; di Cerbo, V.* ; Schildhaus, H.U.* ; Altmüller, J.* ; Baessmann, I.* ; Becker, C.* ; de Wilde, B.* ; Vandesompele, J.* ; Böhm, D.* ; Ansén, S.* ; Gabler, F.* ; Wilkening, I.* ; Heynck, S.* ; Heuckmann, J.M.* ; Lu, X.* ; Carter, S.L.* ; Cibulskis, K.* ; Banerji, S.* ; Getz, G.* ; Park, K.S.* ; Rauh, D.* ; Grütter, C.* ; Fischer, M.* ; Pasqualucci, L.* ; Wright, G.* ; Wainer, Z.* ; Russell, P.* ; Petersen, I.* ; Chen, Y.* ; Stoelben, E.* ; Ludwig, C.* ; Schnabel, P.A.* ; Hoffmann, H.* ; Muley, T.* ; Brockmann, M.M.* ; Engel-Riedel, W.* ; Muscarella, L.A.* ; Fazio, V.M.* ; Groen, H.J.M.* ; Timens, W.* ; Sietsma, H.* ; Thunnissen, E.* ; Smit, E.* ; Heideman, D.A.* ; Snijders, P.J.* ; Cappuzzo, F.* ; Ligorio, C.* ; Damiani, S.* ; Field, J.* ; Solberg, S.* ; Brustugun, O.T.* ; Lund-Iversen, M.* ; Sänger, J.* ; Clement, J.H.* ; Soltermann, A.* ; Moch, H.* ; Weder, W.* ; Solomon, B.* ; Soria, J.C.* ; Validire, P.* ; Besse, B.* ; Brambilla, E.* ; Brambilla, C.* ; Lantuejoul, S.* ; Lorimier, P.* ; Schneider, P.M.* ; Hallek, M.* ; Pao, W.* ; Meyerson, M.* ; Sage, J.* ; Shendure, J.* ; Schneider, R.* ; Büttner, R.* ; Wolf, J.* ; Nürnberg, P.* ; Perner, S.* ; Heukamp, L.C.* ; Brindle, P.K.* ; Haas, S.* ; Thomas, R.K.*

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Nat. Genet. 44, 1104-1110 (2012)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis. We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an extremely high mutation rate of 7.4±1 protein-changing mutations per million base pairs. Therefore, we conducted integrated analyses of the various data sets to identify pathogenetically relevant mutated genes. In all cases, we found evidence for inactivation of TP53 and RB1 and identified recurrent mutations in the CREBBP, EP300 and MLL genes that encode histone modifiers. Furthermore, we observed mutations in PTEN, SLIT2 and EPHA7, as well as focal amplifications of the FGFR1 tyrosine kinase gene. Finally, we detected many of the alterations found in humans in SCLC tumors from Tp53 and Rb1 double knockout mice. Our study implicates histone modification as a major feature of SCLC, reveals potentially therapeutically tractable genomic alterations and provides a generalizable framework for the identification of biologically relevant genes in the context of high mutational background.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
7.283
924
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2012
HGF-reported in Year 0
ISSN (print) / ISBN 1061-4036
e-ISSN 1546-1718
Journal Nature Genetics
Quellenangaben Volume: 44, Issue: 10, Pages: 1104-1110 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place New York, NY
Reviewing status Peer reviewed
Institute(s) Institute of Functional Epigenetics (IFE)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502800-001
PubMed ID 22941188
DOI 10.1038/ng.2396
Erfassungsdatum 2012-12-31
[➜Report correction]